Literature DB >> 8837913

Continuing clozapine despite neutropenia.

M L Wesson1, D M Finnegan, P I Clark.   

Abstract

BACKGROUND: A 40-year-old chronic schizophrenic patient whose psychosis and associated violent behaviour resolved on clozapine, required chemotherapy for a testicular teratoma with pulmonary metastases. His treatment was initially delayed due to refusal to consent. TREATMENT: The patient finally agreed to orchidectomy and cytotoxic therapy, and following agreement by the CPMS, clozapine continued to be dispensed despite neutropenia and 'red alert' status on full blood count. DISCUSSION: This is the only patient to continue clozapine despite 'red alert' status, and as such is an exceptional case, but may open the way for such patients in the future.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8837913     DOI: 10.1192/bjp.168.2.217

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  5 in total

Review 1.  Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.

Authors:  Eromona Whiskey; David Taylor
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 2.  Clozapine treatment of refractory schizophrenia during essential chemotherapy: a case study and mini review of a clinical dilemma.

Authors:  Nazife Gamze Usta; Cana Aksoy Poyraz; Melih Aktan; Alaattin Duran
Journal:  Ther Adv Psychopharmacol       Date:  2014-12

3.  Use of clozapine alongside chemotherapy in a treatment-resistant bipolar disorder patient with ovarian carcinoma: A case report and brief review.

Authors:  Ashish Pakhre; Aarya Krishnan; Raman Deep Pattanayak; Sudhir K Khandelwal
Journal:  Indian J Psychiatry       Date:  2016 Oct-Dec       Impact factor: 1.759

4.  Clozapine reinitiation following a "red result" secondary to chemotherapy.

Authors:  Tariq Munshi; Mir Mazhar; Tariq Hassan
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-27       Impact factor: 2.570

5.  Clozapine and cancer treatment: Adding to the experience and evidence.

Authors:  Jayita K Deodhar; Kumar Prabhash; Jai P Agarwal; Pankaj Chaturvedi
Journal:  Indian J Psychiatry       Date:  2014-04       Impact factor: 1.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.